[70] A. Nikolay, J. de Grooth, Y. Genzel, J. A. Wood, and U. Reichl, “Virus harvesting

in perfusion culture: Choosing the right type of hollow fiber membrane,”

Biotechnol. Bioeng., vol. 117, no. 10, pp. 3040–3052, 2020.

[71] J. Shevitz, “Fluid filtration system patent 6544424,” Grant, April 8, 2003, Refined

Technology Company, Jerry Shevitz, 2000.

[72] S. R. Hadpe, A. K. Sharma, V. V. Mohite, and A. S. Rathore, “ATF for cell culture

harvest clarification: mechanistic modelling and comparison with TFF,” J. Chem.

Technol. Biotechnol., vol. 92, no. 4, pp. 732–740, 2017.

[73] J. Warnock and M. Al-Rubeai, “Production of Biologics from Animal Cell

Cultures,” in Applications of Cell Immobilisation Biotechnology, V. Nedović and

R. Willaert, Eds. Dordrecht: Springer Netherlands, 2005, pp. 423–438.

[74] J. M. Bielser, M. Wolf, J. Souquet, H. Broly, and M. Morbidelli, “Perfusion

mammalian cell culture for recombinant protein manufacturing - A critical review,”

(in eng), Biotechnol. Adv., vol. 36, no. 4, pp. 1328–1340, Jul–Aug. 2018.

[75] C. Zhan et al., “Low shear stress increases recombinant protein production and high

shear stress increases apoptosis in human cells,” (in eng), iScience, vol. 23, no. 11,

p. 101653, Nov. 2020.

[76] M. F. Clincke, C. Mölleryd, Y. Zhang, E. Lindskog, K. Walsh, and V. Chotteau,

“Very high density of CHO cells in perfusion by ATF or TFF in WAVE bior-

eactor™. Part I. Effect of the cell density on the process,” (in eng), Biotechnol.

Prog, vol. 29, no. 3, pp. 754–767, May-Jun. 2013.

[77] V. Jäger, “High Density Perfusion Culture of Animal Cells Using a Novel Continuous

Flow Centrifuge,” in Animal Cell Technology: Basic & Applied Aspects: Proceedings

of the Fourth Annual Meeting of the Japanese Association for Animal Cell

Technology, Fukuoka, Japan, 13–15 November 1991, H. Murakami, S. Shirahata, and

H. Tachibana, Eds. Dordrecht: Springer Netherlands, 1992, pp. 209–216.

[78] T. Björling, U. Dudel, and C. Fenge, “Evaluation of a cell separator in large scale

perfusion culture,” in Animal Cell Technology:Developments Towards the 21st

Century, E. C. Beuvery, J. B. Griffiths, W. P. Zeijlemaker, Eds. Dordrecht:

Springer, 1995, pp. 671–675.

[79] M. Johnson, S. Lanthier, B. Massie, G. Lefebvre, and A. A. Kamen, “Use of the

centritech lab centrifuge for perfusion culture of hybridoma cells in protein-free

medium,” Biotechnol. Prog., vol. 12, no. 6, pp. 855–864, 1996.

[80] G. Jänicke, C. Sauter, R. Bux, and J. Haas, “Characterisation of shake flasks for

cultivation of animal cell cultures,” Dordrecht, 2007. Netherlands: Springer,

pp. 727–731.

[81] T. Bissinger et al., “Semi-perfusion cultures of suspension MDCK cells enable high

cell concentrations and efficient influenza A virus production,” Vaccine, vol. 37,

no. 47, pp. 7003–7010, 2019

[82] Y. Shen and K. Yanagimachi, “CFD-aided cell settler design optimization and scale-

up: effect of geometric design and operational variables on separation performance,”

(in eng), Biotechnol. Prog., vol. 27, no. 5, pp. 1282–1296, Sep-Oct. 2011.

[83] J. H. Vogel et al., “A new large-scale manufacturing platform for complex bio-

pharmaceuticals,” (in eng), Biotechnol. Bioeng., vol. 109, no. 12, pp. 3049–3058,

Dec. 2012.

[84] M. Pohlscheidt et al., “Optimizing capacity utilization by large scale 3000 L per-

fusion in seed train bioreactors,” (in eng), Biotechnol. Prog., vol. 29, no. 1,

pp. 222–229, Jan-Feb. 2013.

[85] R. G. F. Alvim, T. M. Lima, J. L. Silva, G. A. P. de Oliveira, and L. R. Castilho,

“Process intensification for the production of yellow fever virus-like particles as

potential recombinant vaccine antigen,” (in eng), Biotechnol. Bioeng., vol. 118,

no. 9, pp. 3581–3592, Sep. 2021.

Process intensification

171